Dulcolax marketing lures Korean drug makers

Boehringer Ingelheim Korea is seeking a promising Korean partner to market its leading product Dulcolax, which has been distributed by Zuellig Pharma Korea.

Boehringer is said to select one Korean company as its partner, but local leading wholesalers have expressed negative response to the company due to the latter’s sales policy.

Sources said Yuhan Corporation and Dong-A will be the next...